COMP <GO>
MVST vs TMO // 10Y YIELD & FRED MACRO BETA
Microvast Holdings Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: MVST 3
— TMO 8
■ METRIC PARITY
LAST: $0.62 (+0.23%) • MKT CAP: $239.8M
macro-sensitivity
—
LAST: $709.18 (+0.71%) • MKT CAP: $262.22B
macro-sensitivity
0.94
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MVST VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MVST | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 28.60% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 1.80% | 9.30% | -7.50 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 5.7x | 30.4x | -24.70 | MVST | /valuation <GO> |
| Free Cash Flow Yield | 23.38% | 2.40% | +20.98 | MVST | /fcf-yield <GO> |
| Operating Margin | 1.60% | 17.40% | -15.80 | TMO | /operating-margins <GO> |
| Net Profit Margin | -6.80% | 15.10% | -21.90 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 12.60% | 3.90% | +8.70 | MVST | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | 4.50 | -4.30 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.4 | 62.9 | -14.55 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 36.3x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $239.8M | $262.22B | -$261.98B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MVST REV | TMO REV | MVST GROSS % | TMO GROSS % | MVST FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $427.5M | $44.56B | 28.6% | — | $56.1M | $6.29B |
| FY 2024 | $379.8M | $42.88B | 31.5% | — | -$24.9M | $7.27B |
| FY 2023 | $306.6M | $42.86B | — | — | -$75.3M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MVST // BETA —
TMO // BETA 0.94